PTPRC and acute myeloid leukemia: Moreover, we analyzed the AML engraftment levels in the BMs also by immunohistochemistry (CD45+ IHC) and checked the cell cycle status of the resistant cells by Ki67 staining (Supplementary Fig. 4B, AML9).